Enliven Therapeutics Inc Sustainability Reports
Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its initial pipelines focus on precision oncology programs including product candidates designed for targeted cancer treatments.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00CP3BDF2
1 reports from 2023 to 2023
Company Profile
Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its initial pipelines focus on precision oncology programs including product candidates designed for targeted cancer treatments.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
